• This record comes from PubMed

Depressive symptoms and levels of C-reactive protein: a population-based study

. 2009 Mar ; 44 (3) : 217-22. [epub] 20080811

Language English Country Germany Media print-electronic

Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Grant support
064947/Z/01/Z Wellcome Trust - United Kingdom
R01 AG023522 NIA NIH HHS - United States
R01 AG013196 NIA NIH HHS - United States
081081/Z/06/Z Wellcome Trust - United Kingdom
1R01 AG23522-01 NIA NIH HHS - United States

BACKGROUND: Depression and depressive symptoms have been repeatedly linked to elevated levels of C-reactive protein (CRP) but questions remain as to the statistical robustness of the association and particularly whether the association between depression and CRP reflects the presence of a chronic disease. METHODS: A random sample of 6,126 men and women aged 45-69 years was examined in a cross-sectional study in seven towns in the Czech Republic. Depressive symptoms were assessed by the Center for Epidemiologic Studies Depression (CESD) scale. RESULTS: Center for Epidemiologic Studies Depression score was significantly related to increased levels of CRP in a linear fashion. After controlling for a range of potential confounders, subjects with depressive symptoms (CESD score >or= 16) had CRP concentrations 0.43 mg/l (95% CI 0.16-0.72) higher than those without symptoms. The association remained significant when study sample was restricted to healthy subjects; among individuals who did not report any chronic disease, the difference between those with and without depressive symptoms was 0.44 mg/l (95% CI 0.14-0.74), and among persons who did not visit a doctor in the last 12 months the difference was 1.20 mg/l (95% CI 0.52-1.87). CONCLUSIONS: These results confirm that there is a statistically robust association between depressive symptoms and increased levels of CRP. We did not find evidence that the association is due presence of a chronic condition.

See more in PubMed

Atherosclerosis. 2006 Aug;187(2):415-22 PubMed

N Engl J Med. 2004 Apr 1;350(14):1387-97 PubMed

Br J Psychiatry. 2004 May;184:386-92 PubMed

Psychosom Med. 2003 May-Jun;65(3):347-56 PubMed

BMC Psychiatry. 2001;1:3 PubMed

Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1920-5 PubMed

Arch Intern Med. 1997 Feb 24;157(4):449-54 PubMed

Arch Gen Psychiatry. 1994 Jan;51(1):8-19 PubMed

Brain Behav Immun. 2001 Sep;15(3):199-226 PubMed

Psychosomatics. 2000 Jul-Aug;41(4):372-3 PubMed

Psychol Bull. 2004 Jul;130(4):601-30 PubMed

Eur Heart J. 2006 Dec;27(23):2763-74 PubMed

Am J Epidemiol. 2003 Jan 15;157(2):98-112 PubMed

J Intern Med. 2002 Oct;252(4):283-94 PubMed

Int J Epidemiol. 2006 Aug;35(4):922-31 PubMed

Am J Psychiatry. 1983 Jan;140(1):41-6 PubMed

Acta Psychiatr Scand. 1988 Aug;78(2):176-81 PubMed

Biol Psychiatry. 2006 Oct 15;60(8):825-30 PubMed

Stroke. 2005 Jan;36(1):98-102 PubMed

J Occup Health Psychol. 2005 Oct;10(4):344-62 PubMed

BMJ. 1999 May 29;318(7196):1460-7 PubMed

Brain Behav Immun. 2003 Aug;17(4):233-7 PubMed

Psychol Med. 2007 Dec;37(12):1775-86 PubMed

Br J Addict. 1989 Sep;84(9):1085-92 PubMed

Psychol Med. 2006 Jun;36(6):797-805 PubMed

BMC Public Health. 2006 Oct 18;6:255 PubMed

Psychosom Med. 2004 Sep-Oct;66(5):684-91 PubMed

Psychol Med. 1997 Jan;27(1):231-5 PubMed

Psychol Bull. 1984 Nov;96(3):465-90 PubMed

PLoS Med. 2006 Nov;3(11):e442 PubMed

Int J Epidemiol. 1999 Apr;28(2):219-24 PubMed

Br J Psychiatry. 2001 Oct;179:308-16 PubMed

Psychosom Med. 2004 Sep-Oct;66(5):679-83 PubMed

Alcohol Clin Exp Res. 1998 Apr;22(2 Suppl):4S-14S PubMed

J Am Coll Cardiol. 2007 Nov 20;50(21):2044-50 PubMed

J Psychosom Res. 2002 Jan;52(1):1-23 PubMed

N Engl J Med. 2000 Mar 23;342(12):836-43 PubMed

Eur J Cardiovasc Prev Rehabil. 2006 Apr;13(2):199-206 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...